كالاباساس، كاليفورنيا،, April 10, 2025 (GLOBE NEWSWIRE) — [...] Read more »
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical–stage biopharmaceutical company focused on innovative treatments for central [...] Read more »
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Expects to meet final FDA requirements for full PMA approval in the second quarter
Read more »
Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Prévoit de satisfaire aux exigences finales de la FDA pour [...] Read more »
Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business [...] Read more »
Lantronix lance le nouveau System on module Open-Q 8550CS conçu pour répondre aux besoins de l’IA en périphérie du réseau
IRVINE, Californie, 28 mars 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix bringt neues Open-Q 8550CS System-On-Module auf den Markt, das die Anforderungen von Edge-KI-Computing optimal erfüllt
IRVINE, Kalifornien, March 28, 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix Lança Novo System-On-Module Open-Q 8550CS Projetado para Atender às Necessidades de Edge AI Computing
IRVINE, Califórnia, March 27, 2025 (GLOBE NEWSWIRE) — A Read more »
Lantronix Launches New Open-Q 8550CS System-On-Module Designed to Meet the Needs of Edge AI Computing
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Read more »
La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son système Genio®
INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES
La FDA Délivre à Nyxoah une Lettre [...] Read more »
FDA Issues Nyxoah an Approvable Letter for its Genio® System
INSIDE INFORMATION
REGULATED INFORMATION
FDA Issues Nyxoah an Approvable Letter for its Genio® System
Read more »
Zoom Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
The AI–first open work platform joins the ranks of Waymo, Nvidia, Duolingo, and more
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM), has been named [...] Read more »
Zoom debuts new agentic AI skills and agents for Zoom AI Companion
- Zoom AI Companion expands agentic skills across the entire Zoom platform, using reasoning and memory to take action and orchestrate task execution, conversational self–service, custom agent creation, and [...] Read more »
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into [...] Read more »
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports Fourth Quarter and Financial [...] Read more »